Free Cash Flow Build Up

Fate Therapeutics, Inc. (FATE)

$20.91

+0.57 (+2.80%)
Year
A/P
Revenue
EBITDA
EBIT
Tax Rate
EBIAT
Depreciation
Accounts Receivable
Inventories
Accounts Payable
Capital Expenditure
UFCF
WACC
PV UFCF
SUM PV UFCF